News for Homology Medicines Stock (FIXX)

Homology Medicines Announces First Presentation of Data with HMI-203 In Vivo Gene Therapy Development Candidate for Hunter Syndrome

GlobeNewsWire • 02/08/21

Homology Medicines: $60 Million Pfizer Equity-Investment, 4 Encouraging Candidates, And Competent Management

Seeking Alpha • 12/22/20

Homology Medicines (FIXX) Reports Q3 Loss, Tops Revenue Estimates

Zacks Investment Research • 11/09/20

Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Highlights

GlobeNewsWire • 11/09/20

Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal

InvestorPlace • 11/09/20

Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU

GlobeNewsWire • 11/06/20

Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therapy Clinical Trial for Adults with PKU

GlobeNewsWire • 11/05/20

Analysts Estimate Homology Medicines (FIXX) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research • 11/03/20

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Investigation into Possible Securities Fraud Ongoing

Newsfile Corp • 10/29/20

FIXX SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

Newsfile Corp • 10/27/20

Homology Medicines Unveils New In Vivo Gene Therapy Development Program for Hunter Syndrome

GlobeNewsWire • 10/22/20

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Homology Medicines, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Newsfile Corp • 10/21/20

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

Newsfile Corp • 10/20/20

FIXX INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

Newsfile Corp • 10/16/20

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Homology Medicines, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire • 10/15/20

The Law Offices of Frank R. Cruz Continues Its Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Business Wire • 10/15/20

Rosen, A Global and Leading Law Firm, Announces an Investigation of Securities Claims Against Homology Medicines, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - FIXX

Newsfile Corp • 10/15/20

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Business Wire • 10/15/20

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Business Wire • 10/14/20

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Business Wire • 10/13/20

The Law Offices of Frank R. Cruz Announces Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Business Wire • 10/13/20

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Homology Medicines, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire • 10/13/20

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Business Wire • 10/13/20

Rosen Law Firm Announces an Investigation of Securities Claims Against Homology Medicines, Inc. – FIXX

Business Wire • 10/13/20

Homology Medicines to Participate in Upcoming Conferences

GlobeNewsWire • 09/18/20